Adaptam Therapeutics (private company)
See something wrong or missing? Let us know
Offices:San Sebastian
Industry:BiotechHealth services
Business model:B2B
Adaptam is a biotech startup in Spain developing first-in-class antibody-based therapeutic programs, including ADCs and bispecific antibodies, that target novel glyco-immune checkpoints, selectively expressed in immunosuppressive myeloid cells.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 3.52M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Adaptam Therapeutics
| Name | Criteria | |
|---|---|---|
![]() |
APIM Therapeutics
45%
|
|
![]() |
AptaTargets
45%
|
|
![]() |
Athera
45%
|
|
![]() |
AttgeNO
45%
|
|
![]() |
Biomes
45%
|
|
![]() |
Bionomous
45%
|
|
![]() |
Biotts
45%
|
|
![]() |
Oui
45%
|
|
![]() |
Connecta Therapeutics
45%
|
|
![]() |
FinnAdvance
45%
|
|








Belgium
Netherlands
Austria
Estonia
Iceland
Latvia
Lithuania
France
Ireland
Italy
Portugal
United Kingdom